Patent ID: 11957732
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G | IPC A  G

Claim 1:
2. The method of claim 1, wherein
the cathepsin B binding agent is valine-citrulline;
L is —O(CH2)f(CH2CH2O)g(CH2)hO—;
subscript ‘g’ varies from 10 to 20;
subscript ‘h’ is 2;
R1 is C16 branched alkyl; and
each of R2, R3, or R4 is methyl;
the chemotherapy agent is doxorubicin, Bevacizumab, paclitaxel, docetaxel, cyclophosphamide, cisplatin, carboplatin, gemcitabine, ixabepilone, eribulin, irinotecan, etoposide, vinblastine, or pemetrexed; and
the radionuclide therapy agent is 186/188Re, 177Lu, 153Sm, 90Y, 201Pb, or 198Au.